Compare
Bonk, Inc. vs DSwiss Inc vs cbdMD, Inc. vs Scientist Home Future Health Ltd
| Latest fiscal year | Bonk, Inc. BNKK | DSwiss Inc DQWS | cbdMD, Inc. YCBD | Scientist Home Future Health Ltd SHFH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-09-30 | 2025-12-31 |
| Revenue | $2.12M | $2.92M | $19.19M | $204.1K |
| Revenue growth (YoY) | +201.6% | -6.2% | -1.5% | n/a |
| Gross margin | 58.5% | 19.3% | 62.4% | 40.1% |
| Operating margin | n/a | 0.0% | -11.3% | -113.6% |
| Net margin | n/m | -2.6% | -10.6% | -113.6% |
| Net income | -$68.19M | -$76.9K | -$2.04M | -$231.7K |
| EPS (Diluted) | -$17.02 | $0.00 | -$1.09 | -$0.01 |
| Operating cash flow | -$25.28M | -$94.3K | -$1.45M | -$248.3K |
| Free cash flow | n/a | -$135.3K | -$1.64M | -$323.1K |
| Cash & equivalents | n/a | $285.0K | $2.26M | n/a |
| Total assets | $40.97M | $677.1K | $10.42M | $644.4K |
| Total liabilities | $5.98M | $686.5K | $3.19M | $531.0K |
| Shareholders' equity | $35.00M | -$9.3K | $7.23M | $113.4K |
| Return on year-end equity | -194.8% | n/a | -28.2% | -204.4% |
| Shares outstanding | 7.75M | 206.90M | 8.92M | 23.72M |
Revenue, most recent five fiscal years
| Fiscal year | Bonk, Inc. | DSwiss Inc | cbdMD, Inc. | Scientist Home Future Health Ltd |
|---|---|---|---|---|
| Latest | $2.12M Ended 2025-12-31 | $2.92M Ended 2025-12-31 | $19.19M Ended 2025-09-30 | $204.1K Ended 2025-12-31 |
| 1 year earlier | $702.0K Ended 2024-12-31 | $3.11M Ended 2024-12-31 | $19.48M Ended 2024-09-30 | n/a |
| 2 years earlier | $202.7K Ended 2023-12-31 | $1.47M Ended 2023-12-31 | $24.16M Ended 2023-09-30 | n/a |
| 3 years earlier | $120.6K Ended 2022-12-31 | $1.85M Ended 2022-12-31 | $35.40M Ended 2022-09-30 | n/a |
| 4 years earlier | $2.88M Ended 2021-12-31 | $1.96M Ended 2021-12-31 | $44.48M Ended 2021-09-30 | n/a |